Navigation Links
Lifestyle intervention improves risk factors in type 2 diabetes
Date:10/1/2010

o 29.9 is overweight, and 30 or more is obese. Thirty-seven percent of participants were from racial and ethnic minority groups, and approximately 60 percent were women. Over 94 percent of participants remain involved after four years and will continue to be followed for up to 13.5 years.

Over the first four years of Look AHEAD, participants in both groups showed positive changes in their health. On average, across all four years, participants in the intensive lifestyle group lost significantly more weight than participants in the support and education group. On average, members of the lifestyle group lost 6.2 percent of their initial body weight, and members of the support and education group lost 0.9 percent of their initial body weight. The intensive intervention group also experienced greater improvements in fitness, diabetes control, blood pressure, HDL (good) cholesterol, and triglycerides. The diabetes support group showed larger reductions in LDL (bad) cholesterol, a change associated with the increased use of cholesterol-lowering medications. The study results do not break down results by demographic groups such as gender, age, race or ethnicity.

"This important study shows that lifestyle changes have long-term favorable effects on diabetes control and cardiovascular disease risk factors in overweight or obese individuals with type 2 diabetes," said Griffin P. Rodgers, M.D., director of the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), the primary sponsor of the study.

"It is important to note that participants in the intensive lifestyle group and the diabetes education and support group have had positive changes in their weight and their cardiovascular risk factors over the four years," said study chair Rena Wing, Ph.D., of the Miriam Hospital/the Warren Alpert Medical School of Brown University in Providence, R.I.

Longer-term follow-up of Look AHEAD participants will determine whether i
'/>"/>

Contact: Rita Zeidner
niddkmedia@mail.nih.gov
301-435-8112
NIH/National Institute of Diabetes and Digestive and Kidney Diseases
Source:Eurekalert

Page: 1 2 3

Related medicine news :

1. LifestyleMom.com and the LifestyleMom Radio Cafe Aim to Help Women Create a Family Life and "Me Life" That They Truly Love
2. Moms Lifestyle in Early Pregnancy Affects Babys Size
3. For Valentine's Day, Lifestyle Correspondent and Her Two Sets of Twins Show a Little Love Where Its Needed the Most
4. Gilsbar's Health & Lifestyle Management Program Wins First Place Award at the National Workforce Health Economics Summit
5. Want to Live a Healthier Lifestyle? Now Theres an App for That, Too!
6. Introducing KePRO(TM) Engage Health - A Revolutionary Wellness & Lifestyle Management Company
7. Cell Science Systems Recruits Seasoned Executive to Head New Lifestyle Medicine & Nutritional Solution for Health Care Professionals
8. Free Anti-Aging Teleseminar Teaches People Key Lifestyle Changes To Maximize Longevity
9. SeaShine, LLC Announces the Launch of SeaShine Online Magazine, a Magazine for Women Who Positively Impact their Communities through Transparent Lifestyles
10. Lifestyle factors significantly impact survival of non-Hodgkins lymphoma patients, study finds
11. A more active lifestyle crucial for day-to-day function in COPD patients
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/29/2014)... July 29, 2014 A simplified anesthesia procedure may ... the cause of airway obstruction in patients with severe ... Analgesia . , Dr. Joshua H. Atkins and Dr. ... their colleagues have developed a new "ramp control" anesthetic ... show the "obstructive anatomy" responsible for sleep apnea. The ...
(Date:7/29/2014)... CRN International has promoted a longtime executive ... Upton, an 11-year veteran at the radio marketing company, ... managing the day-to-day execution of all CRN client campaigns. ... all activities for CRN clients, which include some ... The department interfaces directly with clients, sets project timelines ...
(Date:7/29/2014)... (PRWEB) July 29, 2014 1WorldSync ... world’s leading healthcare suppliers will utilize the Global ... product information network to share product information with ... other trading partners across their global supply chain. ... ID at B. Braun: "B. Braun serves customers ...
(Date:7/29/2014)... July 29, 2014 The Affordable Care ... model of all hospitals. Studies show that over 400 ... simple, easy, low cost tool that great hospitals use ... 20 to 25%. , Their secret? Debriefing - the ... at the end of an operational event. Debriefing is ...
(Date:7/29/2014)... Kathleen Doheny HealthDay Reporter , ... low risk of cardiovascular disease may be able to take ... without harming their hearts, according to a new study. ... hormone replacement therapy had harmful effects on the heart. But, ... hormone treatments, and much further past menopause. In ...
Breaking Medicine News(10 mins):Health News:New anesthesia technique helps show cause of obstruction in sleep apnea 2Health News:New anesthesia technique helps show cause of obstruction in sleep apnea 3Health News:CRN International Names New Director to Lead Client Services Department 2Health News:B. Braun Selects 1WorldSync Unique Device Identification and Product Information Solution 2Health News:B. Braun Selects 1WorldSync Unique Device Identification and Product Information Solution 3Health News:One Brilliant Economic Survival Tool You Can Steal from the World's Best Hospitals 2Health News:One Brilliant Economic Survival Tool You Can Steal from the World's Best Hospitals 3Health News:Early Hormone Therapy May Be Safe for Women's Hearts 2Health News:Early Hormone Therapy May Be Safe for Women's Hearts 3
... the development of muscles.Da-Zhi Wang and other researchers of the ... the genes are among a recently discovered group of genes ... in the past few years have they been recognised as ... study authors said in an article that appeared in the ...
... experience with China, Pakistani pharmaceutical companies are keen to ... government // to relax the stringent visa norms. ... raw materials provided by the Chinese, apart from the ... problems with the Chinese, though their rates are cheaper ...
... Research Center has reported that maintaining the current recommended ... of cardiovascular disease. The researcher has asked the ... patients less than the recommended levels by aggressive blood ... is used to monitor the average amount of blood ...
... Baruch College has reported in his recent article that having ... . Dr. Brind has compiled data from recent studies of ... American Physicians and Surgeons. ,Professor Brind, ... that pregnancies leading to miscarriage or induced abortions does not ...
... obese people are in increased risk of developing eye ... Belkin and Zohar Habot-Wilner // , Goldschleger Eye Institute, ... and found that risk of developing eye problems are ... link between obesity and other chronic diseases and cancers. ...
... cholesterol can do to people. High-fat diets cause many patients' ... // to know what they consume. ,Now, new rules ... avoid trans fats, which plug arteries, and have been linked ... ,Trans fats are a result of manufacturers adding ...
Cached Medicine News:Health News:Pakistan drug companies seek trade ties with India 2Health News:Food labels to include information on trans fats in US 2Health News:Food labels to include information on trans fats in US 3
(Date:7/28/2014)... , July 28, 2014 STAAR Surgical Company ... and marketer of implantable lenses and delivery systems for ... quarter results and conference call with investors to July ... 2014.  The Company rescheduled the release date and conference ... services for Hideo Watanabe , President of STAAR ...
(Date:7/28/2014)... 2014 Reportbuyer.com has added a new market ... 2014-2018 https://www.reportbuyer.com/product/2225723/Global-Bone-Densitometers-Market-2014-2018.html ... a special type of X-ray test used to measure ... primarily to detect osteopenia or osteoporosis, diseases in which ... fractures is high. The purpose of bone densitometry is ...
(Date:7/28/2014)... -- June 28 th , 2014 – Oncolab, the ... cancer test, is making its AACC debut (booth #4051) at ... is a serum-based in vitro immunoassay, has been run for ... in the fight against cancer recurrence. Photo - ... million cancer survivors in the US alone, the race is ...
Breaking Medicine Technology:STAAR Surgical Moves Second Quarter Earnings Release and Conference Call One Day to July 31 2Global Bone Densitometers Market 2014-2018 2Global Bone Densitometers Market 2014-2018 3Global Bone Densitometers Market 2014-2018 4Global Bone Densitometers Market 2014-2018 5Oncolab, Inc. Exhibits Pioneering AMAS Cancer Test at AACC 2
... - Amgen,(Nasdaq:AMGN) today presented the results from a ... safety of Aranesp(R) (darbepoetin alfa) for the,treatment of ... or radiotherapy ("the 103 study"). Aranesp is not,approved ... these patients. These,results were presented in an oral ...
... therapeutic approach for the treatment,of early and metastatic ... - AEterna,Zentaris Inc. , a global, pure play ... presented an,abstract outlining in vivo data for its ... at the American,Association for Cancer Research (AACR) Annual ...
Cached Medicine Technology:Aranesp Phase 3 Study in Patients with Active Cancer Not Receiving,Concurrent Chemotherapy or Radiotherapy Presented at AACR Annual,Meeting 2Aranesp Phase 3 Study in Patients with Active Cancer Not Receiving,Concurrent Chemotherapy or Radiotherapy Presented at AACR Annual,Meeting 3Aranesp Phase 3 Study in Patients with Active Cancer Not Receiving,Concurrent Chemotherapy or Radiotherapy Presented at AACR Annual,Meeting 4Aranesp Phase 3 Study in Patients with Active Cancer Not Receiving,Concurrent Chemotherapy or Radiotherapy Presented at AACR Annual,Meeting 5Aranesp Phase 3 Study in Patients with Active Cancer Not Receiving,Concurrent Chemotherapy or Radiotherapy Presented at AACR Annual,Meeting 6Aranesp Phase 3 Study in Patients with Active Cancer Not Receiving,Concurrent Chemotherapy or Radiotherapy Presented at AACR Annual,Meeting 7AEterna Zentaris Discloses In Vivo Data for its GHRH Antagonist,JMR-132 at the AACR Annual Meeting in Los Angeles 2AEterna Zentaris Discloses In Vivo Data for its GHRH Antagonist,JMR-132 at the AACR Annual Meeting in Los Angeles 3
... The Leica MS2 is designed to perfectly ... as multidisciplinary use. The Leica MS2 combines ... M500 N with a innovative stand concept ... brakes, patented ABC balancing system for the ...
... loupes are quality surgical loupes featuring ... the healthcare professional a larger field ... field. Each set of SheerVision Loupes ... wooden box and includes side shields, ...
Surgical Loupes...
... The 1.5T Magnetom Sonata is a system ... research system and for cardiovascular and neuroradiological ... supported by previously stored optimized sequences, clinical ... is the fastest MR system in the ...
Medicine Products: